In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Safety and efficacy of the novel esc 0h/1h-protocol for rapid rule-out of myocardial infarction among women and men

Session Poster session 5

Speaker Maria Rubini Gimenez

Event : ESC Congress 2016

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Acute Cardiac Care
  • Session type : Poster Session

Authors : M Rubini Gimenez (Basel,CH), R Twerenbold (Basel,CH), K Wildi (Basel,CH), T Reichlin (Basel,CH), C Mueller (Basel,CH)

Authors:
M. Rubini Gimenez1 , R. Twerenbold1 , K. Wildi1 , T. Reichlin1 , C. Mueller1 , 1University Hospital Basel, Department of Cardiology - Basel - Switzerland ,

Citation:
European Heart Journal ( 2016 ) 37 ( Abstract Supplement ), 980

Background: We aimed to prospectively evaluate the safety and efficacy of the new ESC rapid 0h/1h-rule-out protocol for acute myocardial infarction (AMI), among women and men in order to assess potential gender-inequalities.

Methods: We enrolled consecutive patients presenting to the ED with suspected AMI in a prospective international multicenter study. Excluded were patients with ST-segment elevation or no available high sensitivity cardiac troponin (hs-cTn)T levels. The final diagnosis was adjudicated by two independent cardiologists. The safety and efficacy of the ESC 0h/1h rule-out protocol, based on LOD (Undetectable levels of hs-cTnT at presentation) in combination with hs-cTnT 1h-algorithm was evaluated. Safety was quantified as the negative predictive value (NPV) for AMI in the rule-out zone. Efficacy was quantified as the percentage of the overall cohort assigned to the rule-out zone.

Results: Among all 2213 patients, 32% were women and 68% men. AMI was the final diagnosis in 17% of patients (14% of women and 19% of men, p=0.019). Using the ESC 0h-1h rule-out protocol achieved a very high safety, with a NPV of 99.6% (95% CI, 98.4–100%) among women and 100% (95% CI, 99.6–100%) among men, p=ns. Regarding efficacy, the ESC rule-out protocol classified about 64% of women and 57% of men with suspected AMI) p=0.002 Conclusions: The current ESC 0h1h-rule-out protocol using t the combination of LOD and 1h algorithm hs-cTnT is safe and effective and provides comparable results

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are